Dysregulation of host cellular genes targeted by human papillomavirus (HPV) integration contributes to HPV-related cervical carcinogenesis

International Journal of Cancer

Volumn 138, Issue 5, 2016, Pages 1163-1174

  Zhang, Ruiyang ^a   Shen, Congle ^a   Zhao, Lijun ^b   Wang, Jianliu ^b   McCrae, Malcolm ^c   Chen, Xiangmei ^a   Lu, Fengmin ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^c INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

cervical cancer; functional annotation analysis; HPV; integration; MPPED2; MYC

Indexed keywords

VIRUS DNA; MPPED2 PROTEIN, HUMAN; PHOSPHODIESTERASE;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CHROMATIN; CONTROLLED STUDY; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN CHROMOSOME; HUMAN GENOME; HUMAN TISSUE; INTEGRATION TARGETED CELLULAR GENE; MPPED2 GENE; ONCOGENE MYC; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS; VIRUS DNA CELL DNA INTERACTION; WART VIRUS; GENE EXPRESSION REGULATION; GENETICS; PAPILLOMAVIRIDAE; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; GENOME, HUMAN; HUMANS; PAPILLOMAVIRIDAE; PHOSPHORIC DIESTER HYDROLASES; UTERINE CERVICAL NEOPLASMS; VIRUS INTEGRATION;

EID: 84955671594     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29872     Document Type: Article

References (25)

1. Jemal A, Bray F, Center MM, et al., Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Munoz N, Bosch FX, de Sanjose S, et al., Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-27.
3. Castellsague X., Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol 2008; 110: S4-7.
4. de Sanjose S, Quint WG, Alemany L, et al., Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010; 11: 1048-56.
5. Li N, Franceschi S, Howell-Jones R, et al., Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer 2011; 128: 927-35.
6. de Miguel FJ, Sharma RD, Pajares MJ, et al., Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer. Cancer Res 2014; 74: 1105-15.
7. Werness BA, Levine AJ, Howley PM., Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990; 248: 76-9.
8. Ghittoni R, Accardi R, Hasan U, et al., The biological properties of E6 and E7 oncoproteins from human papillomaviruses. Virus Genes 2010; 40: 1-13.
9. Howley PM, Munger K, Werness BA, et al., Molecular mechanisms of transformation by the human papillomaviruses. Princess Takamatsu Symp 1989; 20: 199-206.
10. Corden SA, Sant-Cassia LJ, Easton AJ, et al., The integration of HPV-18 DNA in cervical carcinoma. Mol Pathol 1999; 52: 275-82.
11. Xu B, Chotewutmontri S, Wolf S, et al., Multiplex Identification of human papillomavirus 16 DNA integration sites in cervical carcinomas. PLoS One 2013; 8: e66693.
12. Dall KL, Scarpini CG, Roberts I, et al., Characterization of naturally occurring HPV16 integration sites isolated from cervical keratinocytes under noncompetitive conditions. Cancer Res 2008; 68: 8249-59.
13. Li X, Zhang J, Yang Z, et al., The function of targeted host genes determines the oncogenicity of HBV integration in hepatocellular carcinoma. J Hepatol 2014; 60: 975-84.
14. Reuter S, Bartelmann M, Vogt M, et al., APM-1, a novel human gene, identified by aberrant co-transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB/POZ-zinc finger protein with growth inhibitory activity. EMBO J 1998; 17: 215-22.
15. Schmitz M, Driesch C, Beer-Grondke K, et al., Loss of gene function as a consequence of human papillomavirus DNA integration. Int J Cancer 2012; 131: E593-602.
16. Wentzensen N, Vinokurova S, von Knebel DM., Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res 2004; 64: 3878-84.
17. Lv J, Zhu P, Yang Z, et al., PCDH20 functions as a tumour-suppressor gene through antagonizing the Wnt/beta-catenin signalling pathway in hepatocellular carcinoma. J Viral Hepat 2015; 22: 201-11.
18. Wagner TA, McLaughlin S, Garg K, et al., HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection. Science 2014; 345: 570-3.
19. Adey A, Burton JN, Kitzman JO, et al., The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line. Nature 2013; 500: 207-11.
20. Yali Z, Rork K, Bin N, et al., Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion. Cancer Res 2007; 67: 10163-72.
21. Liguori L, Andolfo I, de Antonellis P, et al., The metallophosphodiesterase Mpped2 impairs tumorigenesis in neuroblastoma. Cell Cycle 2012; 11: 569-81.
22. Sauermann M, Sahin O, Sultmann H, et al., Reduced expression of vacuole membrane protein 1 affects the invasion capacity of tumor cells. Oncogene 2008; 27: 1320-6.
23. Qian Q, Zhou H, Chen Y, et al., VMP1 related autophagy and apoptosis in colorectal cancer cells: VMP1 regulates cell death. Biochem Biophys Res Commun 2014; 443: 1041-7.
24. Guo L, Yang LY, Fan C, et al., Novel roles of Vmp1: inhibition metastasis and proliferation of hepatocellular carcinoma. Cancer Sci 2012; 103: 2110-9.
25. Hu Z, Zhu D, Wang W, et al., Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism. Nat Genet 2015; 47: 158-63.